Showing results (111-120 of 207) with videos related to

Sort By:
Pageof 21
Psychopharmacology|February 28, 2002
Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphineEric C Strain, Sharon L Walsh, George E Bigelow
Journal of Opioid Management|December 19, 2019
Increases in body mass index and cardiovascular risk factors during methadone maintenance treatmentMary M Sweeney, Denis G Antoine, Leticia Nanda, et al.
American Journal of Public Health|November 17, 2012
Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug usersJennifer R Havens, Michelle R Lofwall, Simon D W Frost, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|December 15, 2017
A qualitative analysis of gabapentin misuse and diversion among people who use drugs in Appalachian KentuckyRachel Vickers Smith, Elaine M Boland, April M Young, et al.
Drug and Alcohol Dependence|May 23, 2007
Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadoneJames Rosado, Sharon L Walsh, George E Bigelow, et al.
Journal of Analytical Toxicology|September 9, 2006
Effect of repeated cocaine administration on detection times in oral fluid and urineRebecca Jufer, Sharon L Walsh, Edward J Cone, et al.
Drug and Alcohol Dependence|October 22, 2020
Introduction to the special issue on the HEALing Communities StudyNabila El-Bassel, Rebecca D Jackson, Jeffrey Samet, et al.
Psychopharmacology|October 3, 2006
Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h periodChristopher J Correia, Sharon L Walsh, George E Bigelow, et al.
Current HIV/AIDS Reports|June 28, 2018
Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and TreatmentJennifer R Havens, Sharon L Walsh, P Todd Korthuis, et al.
Pageof 21